©The Author(s) 2021.
World J Gastrointest Oncol. Nov 15, 2021; 13(11): 1781-1790
Published online Nov 15, 2021. doi: 10.4251/wjgo.v13.i11.1781
Published online Nov 15, 2021. doi: 10.4251/wjgo.v13.i11.1781
Table 1 Baseline characteristics of patients
| Feature | n (%) |
| Gender | |
| Male | 29 (100) |
| Female | 0 (0) |
| Age [yr; median (range)] | 62 (56, 65) |
| Clinical stage | |
| III | 15 (51.7) |
| IV | 14 (48.3) |
| Tumor location | |
| Upper thoracic esophagus | 6 (20.7) |
| Upper part of middle thoracic esophagus | 3 (10.3) |
| Middle thoracic esophagus | 6 (20.7) |
| Lower part of middle thoracic esophagus | 8 (27.6) |
| Lower thoracic esophagus | 6 (20.7) |
- Citation: Yan MH, Liu F, Qu BL, Cai BN, Yu W, Dai XK. Induction chemotherapy with albumin-bound paclitaxel plus lobaplatin followed by concurrent radiochemotherapy for locally advanced esophageal cancer. World J Gastrointest Oncol 2021; 13(11): 1781-1790
- URL: https://www.wjgnet.com/1948-5204/full/v13/i11/1781.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i11.1781